Literature DB >> 17899140

Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome.

Banchhita Sahu1, Ozkan Ozturk, Massimo Ranierri, Paul Serhal.   

Abstract

OBJECTIVE: To compare the oocyte quality and intracytoplasmic sperm injection performance in women with isolated polycystic ovaries or polycystic ovarian syndrome.
DESIGN: Retrospective study.
SETTING: Fertility unit. POPULATION: Three study groups were identified: women with PCO-only morphology (50 cycles), PCOS (51 cycles) and age matched control group (104 cycles) with isolated male factor infertility necessitating ICSI.
METHOD: Controlled ovarian hyperstimulation and ICSI. MAIN OUTCOME MEASURES: Response to gonadotropin stimulation, oocyte and embryo quality, clinical pregnancy rate and pregnancy outcome.
RESULTS: Despite a significantly lower total gonadotropin dose, a significantly higher serum E2 level was attained in both the PCOS and the PCO-only groups compared to the control group. Although significantly more oocytes were retrieved in the PCOS and PCO-only groups, the number of 2-pronuclear embryos was similar to controls. No significant differences were noted in the maturity of the oocytes, oocyte dysmorphism, embryo quality, implantation and pregnancy rates among the three groups. However the clinical miscarriage rate was significantly lower in women with PCO-only morphology group (15.4 versus 31%, P < 0.05) than in the PCOS group.
CONCLUSION: Women with PCO-only appearance have shown to have similar characteristics to women with PCOS in terms of ovarian response to hMG stimulation, oocyte and embryo quality and pregnancy rates. However miscarriage rates were significantly lower in the PCO-only group than the PCOS group. Our findings suggest that factors unrelated to oocyte and embryo morphology present in PCOS patients may be instrumental in adverse reproductive outcomes in these women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899140     DOI: 10.1007/s00404-007-0462-x

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  22 in total

1.  Exposing cultured mouse ovarian follicles under increased gonadotropin tonus to aromatizable androgens influences the steroid balance and reduces oocyte meiotic capacity.

Authors:  Sergio Romero; Johan Smitz
Journal:  Endocrine       Date:  2010-07-20       Impact factor: 3.633

Review 2.  Polycystic ovary syndrome throughout a woman's life.

Authors:  José Bellver; Luis Rodríguez-Tabernero; Ana Robles; Elkin Muñoz; Francisca Martínez; José Landeras; Juan García-Velasco; Juan Fontes; Mónica Álvarez; Claudio Álvarez; Belén Acevedo
Journal:  J Assist Reprod Genet       Date:  2017-09-27       Impact factor: 3.412

3.  The effect of serum and follicular fluid secreted frizzle-related protein-5 on in vitro fertilization outcomes in patients with polycystic ovary syndrome.

Authors:  Zeynep Ozturk Inal; Hasan Ali Inal; Sami Erdem
Journal:  Mol Biol Rep       Date:  2018-09-07       Impact factor: 2.316

4.  Unaltered timing of embryo development in women with polycystic ovarian syndrome (PCOS): a time-lapse study.

Authors:  Linda Sundvall; Kirstine Kirkegaard; Hans Jakob Ingerslev; Ulla Breth Knudsen
Journal:  J Assist Reprod Genet       Date:  2015-05-01       Impact factor: 3.412

5.  Spindle and chromosome configurations of in vitro-matured oocytes from polycystic ovary syndrome and ovulatory infertile women: a pilot study.

Authors:  Rodolpho C Vieira; Ionara D Barcelos; Elisa M Ferreira; Wellington P Martins; Rui A Ferriani; Paula A Navarro
Journal:  J Assist Reprod Genet       Date:  2010-09-04       Impact factor: 3.412

6.  Risk Factors and Methods for Predicting Ovarian Hyperstimulation Syndrome (OHSS) in the in vitro Fertilization.

Authors:  S P Pakhomov; V S Orlova; I N Verzilina; N V Sukhih; A V Nagorniy; A V Matrosova
Journal:  Arch Razi Inst       Date:  2021-11-30

7.  Avoiding OHSS: Controlled Ovarian Low-Dose Stimulation in Women with PCOS.

Authors:  D Fischer; C Reisenbüchler; S Rösner; J Haussmann; P Wimberger; M Goeckenjan
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-06       Impact factor: 2.915

8.  The impact of follicular fluid adiponectin and ghrelin levels based on BMI on IVF outcomes in PCOS.

Authors:  H A Inal; N Yilmaz; U Gorkem; A S Oruc; H Timur
Journal:  J Endocrinol Invest       Date:  2015-09-26       Impact factor: 4.256

Review 9.  Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.

Authors:  Jie Qiao; Huai L Feng
Journal:  Hum Reprod Update       Date:  2010-07-16       Impact factor: 15.610

10.  First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?

Authors:  Christine Decanter; Geoffroy Robin; Patricia Thomas; Maryse Leroy; Catherine Lefebvre; Benoit Soudan; Valerie Lefebvre-Khalil; Brigitte Leroy-Martin; Didier Dewailly
Journal:  Reprod Biol Endocrinol       Date:  2013-06-19       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.